Novelion Services USA, Inc. Suite 400Offer of Employment • March 30th, 2017 • Novelion Therapeutics Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledMarch 30th, 2017 Company Industry JurisdictionAs you are aware, Aegerion Pharmaceuticals, Inc. (“Aegerion”), QLT Inc. and Isotope Acquisition Corp. have agreed to carry out a merger (the “Merger”) on the terms set out in the Agreement and Plan of Merger dated June 14, 2016 (the “Merger Agreement”).
NOVELION 2016 EQUITY INCENTIVE PLAN STOCK OPTION AWARD GRANT NOTICE AND STOCK OPTION AWARD AGREEMENTStock Option Award Agreement • March 30th, 2017 • Novelion Therapeutics Inc. • Pharmaceutical preparations • British Columbia
Contract Type FiledMarch 30th, 2017 Company Industry JurisdictionNovelion Therapeutics Inc. (the “Company”), pursuant to its 2016 Equity Incentive Plan, as amended from time to time (the “Plan”), hereby grants to the individual listed below (“Grantee”), an award (“Award”) of an option (“Option”) to purchase a number of Common Shares, as set forth below. The Option is subject to the conditions and limitations set forth in this Stock Option Award Grant Notice (the “Grant Notice”), the Stock Option Award Agreement attached hereto as Exhibit A (the “Award Agreement”) and the Plan. Unless otherwise defined in this Grant Notice or the Award Agreement, defined terms shall have the meaning set forth in the Plan.
RESTRICTED STOCK UNIT AWARD GRANT NOTICE AND RESTRICTED STOCK UNIT AWARD AGREEMENTRestricted Stock Unit Award Agreement • March 30th, 2017 • Novelion Therapeutics Inc. • Pharmaceutical preparations • British Columbia
Contract Type FiledMarch 30th, 2017 Company Industry JurisdictionNovelion Therapeutics Inc. (the “Company”), pursuant to its 2016 Equity Incentive Plan, as amended from time to time (the “Plan”), hereby grants to the individual listed below (“Grantee”), an award (“Award”) consisting of the number of restricted stock units (“Restricted Stock Units” or “RSUs”) set forth below. Each RSU represents the conditional right to receive, without payment but subject to the conditions and limitations set forth in this Restricted Stock Unit Award Grant Notice (the “Grant Notice”), the Restricted Stock Unit Award Agreement attached hereto as Exhibit A (the “Award Agreement”) and the Plan, one Common Share, subject to adjustment pursuant to Section 16 of the Plan in respect of transactions occurring on or after the date hereof. Unless otherwise defined in this Grant Notice or the Award Agreement, defined terms shall have the meaning set forth in the Plan.
INDEMNITY AGREEMENTIndemnification Agreement • March 30th, 2017 • Novelion Therapeutics Inc. • Pharmaceutical preparations • British Columbia
Contract Type FiledMarch 30th, 2017 Company Industry JurisdictionNOVELION THERAPEUTICS INC., a British Columbia company having a principal place of business at 887 Great Northern Way, Suite 101, Vancouver, British Columbia, Canada V5T 4T5
NOVELION 2016 EQUITY INCENTIVE PLAN STOCK OPTION AWARD GRANT NOTICE AND STOCK OPTION AWARD AGREEMENTStock Option Award Agreement • March 30th, 2017 • Novelion Therapeutics Inc. • Pharmaceutical preparations • British Columbia
Contract Type FiledMarch 30th, 2017 Company Industry JurisdictionNovelion Therapeutics Inc. (the “Company”), pursuant to its 2016 Equity Incentive Plan, as amended from time to time (the “Plan”), hereby grants to the individual listed below (“Grantee”), an award (“Award”) of an option (“Option”) to purchase a number of Common Shares, as set forth below. The Option is subject to the conditions and limitations set forth in this Stock Option Award Grant Notice (the “Grant Notice”), the Stock Option Award Agreement attached hereto as Exhibit A (the “Award Agreement”) and the Plan. Unless otherwise defined in this Grant Notice or the Award Agreement, defined terms shall have the meaning set forth in the Plan.
SUBLEASESublease • March 30th, 2017 • Novelion Therapeutics Inc. • Pharmaceutical preparations • British Columbia
Contract Type FiledMarch 30th, 2017 Company Industry JurisdictionNOW THEREFORE in consideration of the premises and other consideration, the receipt and sufficiency of which are hereby acknowledged by each of the parties, the parties agree as follows:
PERFORMANCE RESTRICTED STOCK UNIT AWARD GRANT NOTICE AND PERFORMANCE RESTRICTED STOCK UNIT AWARD AGREEMENTPerformance Restricted Stock Unit Award Agreement • March 30th, 2017 • Novelion Therapeutics Inc. • Pharmaceutical preparations • British Columbia
Contract Type FiledMarch 30th, 2017 Company Industry JurisdictionNovelion Therapeutics Inc. (the “Company”), pursuant to its 2016 Equity Incentive Plan, as amended from time to time (the “Plan”), hereby grants to the individual listed below (“Grantee”), an award (“Award”) consisting of the target number of performance Restricted Stock Units (“PSUs”) set forth below. Each PSU represents the conditional right to receive, without payment but subject to the conditions and limitations set forth in this Performance Restricted Stock Unit Award Grant Notice (the “Grant Notice”), the Performance Restricted Stock Unit Award Agreement attached hereto as Exhibit A (the “Award Agreement”) and the Plan, one Common Share, subject to adjustment pursuant to Section 16 of the Plan in respect of transactions occurring on or after the date hereof. The portion of the Award that may become vested and earned by Grantee will be determined in accordance with Schedule I to the Award Agreement. Unless otherwise defined in this Grant Notice or Award Agreement, defined terms sh
SUBLEASE RENEWAL AGREEMENTSublease Renewal Agreement • March 30th, 2017 • Novelion Therapeutics Inc. • Pharmaceutical preparations
Contract Type FiledMarch 30th, 2017 Company IndustryNOW THEREFORE THIS AGREEMENT WITNESSES that in consideration of the mutual covenants and agreements between the parties to this Agreement and the sum of Ten Dollars ($10.00) now paid by each party to the other (the receipt and sufficiency of which are hereby acknowledged), the parties agree as follows:
Novelion Services USA, Inc. Suite 400 Wilmington, DE 19808Employment Agreement • March 30th, 2017 • Novelion Therapeutics Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledMarch 30th, 2017 Company Industry JurisdictionAs you are aware, Aegerion Pharmaceuticals, Inc. (“Aegerion”), QLT Inc. and Isotope Acquisition Corp. have agreed to carry out a merger (the “Merger”) on the terms set out in the Agreement and Plan of Merger dated June 14, 2016 (the “Merger Agreement”).
SUBLEASE AMENDING AND EXPANSION AGREEMENTSublease Amending and Expansion Agreement • March 30th, 2017 • Novelion Therapeutics Inc. • Pharmaceutical preparations
Contract Type FiledMarch 30th, 2017 Company IndustryNOW THEREFORE THIS AGREEMENT WITNESSES that in consideration of the mutual covenants and agreements between the parties to this Agreement and the sum of Ten Dollars ($10.00) now paid by each party to the other (the receipt and sufficiency of which are hereby acknowledged), the parties agree as follows: